DAFTAR PUSTAKA

(1)

DAFTAR PUSTAKA

1. World Health Organization (WHO). WHO Director-General’s opening remarks at the Mission briefing on COVID-19 - 12 March 2020. 2020;

Available from: https://www.who.int/director-general/speeches/detail/who- director-general-s-opening-remarks-at-the-mission-briefing-on-covid-19--- 12-march-2020

2. Aziz R, Graharti R. Karakteristik Klinis Corona Virus Disease (COVID-19) pada Kasus Anak-Anak di Dunia. Medula. 2020;10(3):491–5.

3. Pudjiadi AH, Putri ND, Sjakti HA, Yanuarso PB, Gunardi H, Roeslani RD, et al. Pediatric COVID-19: Report From Indonesian Pediatric Society Data Registry. Front Pediatr. 2021;9:1–7.

4. Pemerintah Provinsi Jambi. Data COVID-19 Provinsi Jambi [Internet].

Dinas Komunikasi dan Informatika Provinsi Jambi. Jambi; 2022 [cited 2022 Oct 23]. Available from: https://corona.jambiprov.go.id/v2/

5. Huang X, Wei F, Hu L, Wen L, Chen K. Epidemiology and clinical characteristics of COVID-19. Arch Iran Med [Internet]. 2020;23(4):268–71.

Available from: https://doi.org/10.34172/aim.2020.09

6. She J, Liu L, Liu W. COVID-19 epidemic: Disease characteristics in children. J Med Virol [Internet]. 2020;92(7):747–54. Available from:

http://dx.doi.org/10.1002/jmv.25807

7. Han MS, Choi EH, Chang SH, Jin B Lo, Lee EJ, Kim BN, et al. Clinical Characteristics and Viral RNA Detection in Children with Coronavirus Disease 2019 in the Republic of Korea. JAMA Pediatr. 2021;175(1):73–80.

8. Penna C, Mercurio V, Tocchetti CG, Pagliaro | Pasquale, Tocchetti CG. Sex- related differences in COVID-19 lethality. 2020;

9. James PT, Ali Z, Armitage AE, Bonell A, Cerami C. Could nutrition modulate COVID-19 susceptibility and severity of disease? A systematic review. medRxiv [Internet]. 2021;1(165):1–13. Available from:

https://www.medrxiv.org/content/10.1101/2020.10.19.20214395v2

10. Nurhidayah I, Tamara M, Setyorini D. Karakteristik Covid-19 pada Anak. J

(2)

Ilmu Keperawatan Anak. 2021;4(1):7–18.

11. Hadiyanto ML. Gambaran Hingga Tatalaksana COVID-19 Pada Anak.

Intisari Sains Medis | Intisari Sains Medis [Internet]. 2021;12(1):250–5.

Available from: http://isainsmedis.id/

12. PDPI, PERKI, PAPDI, PERDATIN, IDAI. Pedoman tatalaksana COVID-19 Edisi 4 Januari 2022. Pedoman tatalaksana COVID-19 edisi 4. 2022. 79–85 p.

13. Menteri Kesehatan RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 25 Tahun 2014. 2014;39(1):1–15. Available from:

https://peraturan.bpk.go.id/Home/Download/108349/Permenkes Nomor 25 Tahun 2014.pdf

14. Yagnik PJ, Umscheid J, Khan AW, Ali M, Bhatt P, Desai PH. Pediatric Characteristics of 2019 Novel Coronavirus: Review of Available Published Literature. Clin Pediatr (Phila). 2020;59(9–10):849–52.

15. World Health Organization. A Timeline of WHO’s COVID-19 Response in the WHO European Region [Internet]. 2022. Available from:

https://www.who.int/europe/publications/i/item/WHO-EURO-2021-1772- 41523-56652

16. Razavi A, Davoodi L, Shojaei L, Jafarpour H. Covid-19 in children: A narrative review. Open Access Maced J Med Sci. 2020;8(T1):23–31.

17. Handayani D, Hadi DR, Isbaniah F, Burhan E, Agustin H. Corona Virus Disease 2019. J Respirologi Indones [Internet]. 2022;40(02):1–14. Available from: https://jurnalrespirologi.org/index.php/jri/article/download/101/110 18. Aditia A. Covid-19 : Epidemiologi, Virologi, Penularan, Gejala Klinis,

Diagnosa, Tatalaksana, Faktor Risiko Dan Pencegahan. J Penelit Perawat Prof [Internet]. 2021;3(November):653–60. Available from:

http://jurnal.globalhealthsciencegroup.com/index.php/JPPP%0ACOVID-19 19. World Health Organization (WHO). Living Guidance for clinical management of COVID-19. World Heal Organ [Internet].

2021;(November):63. Available from:

https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2021-2

(3)

20. Levani, Prastya, Mawaddatunnadila. Coronavirus Disease 2019 (COVID- 19): Patogenesis, Manifestasi Klinis dan Pilihan Terapi. J Kedokt dan Kesehat [Internet]. 2021;17(1):44–57. Available from:

https://jurnal.umj.ac.id/index.php/JKK/article/view/6340

21. Satuan Tugas COVID-19 dan Pengurus Pusat Ikatan Dokter Anak Indonesia.

Panduan Klinis Tata Laksana COVID-19 Pada Anak. Indones Pediatr Soc

[Internet]. 2020;3:8–11. Available from:

https://www.papdi.or.id/pdfs/983/Buku Pedoman Tatalaksana COVID-19 5OP Edisi 3 2020.pdf

22. Ikatan Dokter Anak Indonesia. Panduan Klinis Tata Laksana COVID-19 pada Anak. Indones Pediatr Soc [Internet]. 2020;33. Available from:

https://www.idai.or.id/about-idai/idai-statement/panduan-klinis-tatalaksana-covid-19-pada-anak

23. Guo CX, He L, Yin JY, Meng XG, Tan W, Yang GP, et al. Epidemiological and clinical features of pediatric COVID-19. BMC Med [Internet].

2020;18(1):1–7. Available from:

https://pubmed.ncbi.nlm.nih.gov/32762696/

24. World Health Organization (WHO). Clinical management of severe acute respiratory infection when novel coronavirus (2019-nCoV) infection is suspected. World Heal Organ [Internet]. 2020;1–10. Available from:

https://apps.who.int/iris/handle/10665/330893

25. Perhimpunan Dokter Spesialis Patologi Klinik Dan Kedokteran Laboratorium Indonesia PP. Panduan Tatalaksana Pemeriksaan Naat (Nucleic Acid Amplification Test) SARS-CoV-2. Perhimpun Dr Spes Patol Klin Dan Kedokt Lab Indones (PDS PatKLIn). 2021;(5):1–8.

26. Indonesia PPPK dan KL. Panduan Tatalaksana Pemeriksaan Antigen SARS- CoV-2. 2020;(5):1–12.

27. Keputusan Menteri Kesehatan Republik Indonesia. Keputusan menteri kesehatan republik indonesia nomor hk.01.07/menkes/446/2021 tentang penggunaan Rapid Diagnostic Test antigen dalam Pemeriksaan COVID-19.

2021;2019(9):1689–99.

(4)

28. Thamaria N. Penilaian Status Gizi [Internet]. 2017. 317 p. Available from:

http://bppsdmk.kemkes.go.id/pusdiksdmk/wp-

content/uploads/2017/11/PENILAIAN-STATUS-GIZI-FINAL-SC.pdf 29. Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et

al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation.

Vol. 28, Obesity. 2020. p. 1195–9.

30. Yu Y, Ye J, Chen M, Jiang C, Lin W, Lu Y, et al. Malnutrition Prolongs the Hospitalization of Patients with COVID-19 Infection: A Clinical Epidemiological Analysis. J Nutr Heal Aging. 2021;25(3):369–73.

31. Briguglio M, Pregliasco FE, Lombardi G, Perazzo P, Banfi G. The Malnutritional Status of the Host as a Virulence Factor for New Coronavirus SARS-CoV-2. Front Med. 2020;7:1–5.

32. Ikatan Dokter Anak Indonesia. Rekomendasi Ikatan Dokter Anak Indonesia : Asuhan Nutrisi Pediatrik (Pediatric Nutrition Care). Pediatric [Internet].

2011;3(2):5–6. Available from: https://spesialis1.ika.fk.unair.ac.id/wp- content/uploads/2017/03/Rekomendasi-IDAI-Asuhan-Nutrisi-Pediatrik.pdf 33. Armin S, Mirkarimi M, Pourmoghaddas Z, Tariverdi M, Jafrasteh A,

Marhamati N, et al. Iranian Pediatric COVID-19 Epidemiology and Clinical Characteristics. Can J Infect Dis Med Microbiol. 2021;2021:19–23.

34. Dong Y, Mo X, Hu Y, Al E. Epidemiological characteristics of 2143 pediatric patients with 2019 coronavirus disease in China. J Emerg Med.

2020;58(4):712–3.

35. Rinaldi SF, Mujianto B. Metodologi Penelitian dan Statistik [Internet]. 2017.

Available from: http://bppsdmk.kemkes.go.id/pusdiksdmk/wp- content/uploads/2017/11/Metodologi-Penelitian-dan-Statistik-SC.pdf 36. Hartoyo E, Ariyani R, Fitri L, Nurfahmayati T, Qotrunnada SA, Rahmiati R.

Studi Deskriptif dan Analitik COVID-19 pada Anak di Rumah Sakit Umum Daerah Ulin Banjarmasin. Sari Pediatr. 2022;23(5):290.

37. Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in

(5)

Zhejiang, China: an observational cohort study. 2020;20. Available from:

https://www.thelancet.com/action/showPdf?pii=S1473- 3099%2820%2930198-5

38. Grace C. Manifestasi Klinis dan Perjalanan Penyakit pada Pasien Penyakit Coronavirus-2019. Majority [Internet]. 2020;9:49–55. Available from:

https://juke.kedokteran.unila.ac.id/index.php/majority/article/view/2678 39. Sherwood L. Fisiologi Manusia Edisi 9. Suyono J, Iskandar M, Isella V,

Susanti F, Michael, editors. Jakarta: EGC; 2020. 484–485 p.

40. Ismoedijanto. Demam pada Anak. Sari Pediatr. 2000;2(2):103–8.

41. Sukmana M, Yuniarti FA. The Pathogenesis Characteristics and Symptom of Covid-19 in the Context of Establishing a Nursing Diagnosis. J Kesehat Pasak Bumi Kalimantan. 2020;3(1):21.

42. Ulhaq ZS, Soraya GV. Interleukin-6 as a potential biomarker of COVID-19 progression. Med Mal Infect [Internet]. 2020;50(4):382–3. Available from:

43. Lu X, Zhang L, Du H. SARS-CoV-2 Infection in Children. N Engl J Med

[Internet]. 2020; Available from:

44. Gladiola B, Wreksoatmodjo BR. Fatigue sebagai Gejala Sisa COVID-19.

Cermin Dunia Kedokt. 2022;49(4):188.

45. Kedor C, Freitag H, Meyer-Arndt L, Wittke K, Zoller T, Steinbeis F, et al.

Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany: a first analysis of a prospective observational study. medRxiv [Internet]. 2020;(165):1–13.

Available from: https://pubmed.ncbi.nlm.nih.gov/33359928/

46. Zheng G, Wang B, Zhang H, Xie C, Zhang Y, Wen Z, et al. Clinical characteristics of acute respiratory syndrome with SARS-CoV-2 infection in children in South China. Pediatr Pulmonol [Internet]. 2020;55(9):2419–26.

Available from: https://pubmed.ncbi.nlm.nih.gov/32579293/

47. Rokkas T. Gastrointestinal involvement in covid-19: A systematic review and meta-analysis. Ann Gastroenterol. 2020;33(4):355–65.

(6)

48. Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.

49. Mao R, Qiu Y, He J, Tan J, Li X, Liang J. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5.

50. Cheung KS, Hung IFN, Chan PPY, Lung KC, Tso E, Liu R, et al.

Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta- analysis. Gastroenterology. 2020;159(1):81–95.

51. Daneshgaran G, Dubin DP, Gould DJ. Cutaneous Manifestations of COVID- 19: An Evidence-Based Review. Am J Clin Dermatol [Internet].

2020;21(5):627–39. Available from: https://doi.org/10.1007/s40257-020- 00558-4

52. Ananda A, Anggraini DI, Sibero HT, Studi P, Dokter P, Kedokteran F, et al.

Manifestasi Kelainan Kulit pada Penyakit Corona Virus ( COVID-19 ) Cutaneous Manifestations of Coronavirus Disease ( COVID-19 ).

2020;9(April):179–84.

53. Casas D, Catal A, Fern D. Classification of the cutaneous manifestations of COVID-19 : a rapid prospective nationwide consensus study in Spain with 375 cases *. 2020;71–7.

54. Kementerian Kesehatan Republik Indonesia. Alur Pelayanan Pasien COVID-19 [Internet]. 2020 [cited 2022 Dec 5]. Available from:

https://www.kemkes.go.id/article/view/20101700001/begini-alur- pelayanan-pasien-covid-19.html

55. RSUD Raden Mattaher Jambi. Sejarah RSUD Raden Mattaher Jambi [Internet]. [cited 2022 Oct 23]. Available from:

https://www.mattaher.id/tentang-kami/sejarah/

56. Zheng F, Liao C, Fan Q, Chen H, Zhao X, Xie Z. Clinical Characteristics of Children with Coronavirus Disease 2019 in Hubei, China. Curr Med Sci [Internet]. 2020;40(2):275–80. Available from:

(7)

57. Nilanti FS, Renyoet BS. Study Literature: COVID-19 pada Anak dan Risiko Masalah Gizi. J Ilmu Kesehat Indones. 2021;2(2):77–86.

58. Mertens E, Peñalvo JL. The Burden of Malnutrition and Fatal COVID-19: A Global Burden of Disease Analysis. Front Nutr. 2021;7(January):1–12.

59. Nikbakht F, Mohammadkhanizadeh A, Mohammadi E. How does the COVID-19 cause seizure and epilepsy in patients? Thepotential mechanisms. Elsevier [Internet]. 2020; Available from:

60. Zhou Y, Lu K, Pfefferle S, Bertram S, Glowacka I, Drosten C, et al. A Single Asparagine-Linked Glycosylation Site of the Severe Acute Respiratory Syndrome Coronavirus Spike Glycoprotein Facilitates Inhibition by Mannose-Binding Lectin through Multiple Mechanisms. J Virol.

2010;84(17):8753–64.

61. Sykes A, Edwards MR, MacIntyre J, Del Rosario A, Bakhsoliani E, Trujillo- Torralbo MB, et al. Rhinovirus 16-induced IFN-α and IFN-β are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol.

2012;129(6):1506-1514.e6.

62. Wardana VAW, Rosyid AN. Inflammatory Mechanism and Clinical Implication of Asthma in COVID-19. Clin Med Insights Circ Respir Pulm Med. 2021;15.

63. Haiduc A., Ogunjimi M, Shammus R, Mahmood S, Kutty R. COVID-19 and congenital heart disease: An insight of pathophysiology and associated risks.

Cardiol Young [Internet]. 2020;31(2):233–40. Available from:

https://www.cambridge.org/core/journals/cardiology-in-the- young/article/covid19-and-congenital-heart-disease-an-insight-of- pathophysiology-and-associated-

risks/A52045E4D068FC0C82A61ABF8FFFF40E

64. Nigro E, Perrotta F, Polito R, D’Agnano V, Scialò F, Bianco A, et al.

Metabolic perturbations and severe covid-19 disease: Implication of molecular pathways. Int J Endocrinol. 2020;2020.

65. Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour J, et al. Risk

(8)

Factors for Severe COVID-19 in Children. Pediatr Infect Dis J.

2021;40(4):E137–45.

66. Seftiya A, Kosala K. Epidemiologi Karakteristik Pasien Covid-19 di Kalimantan Utara. J Sains dan Kesehat. 2021;3(5).

67. Kementerian Kesehatan Republik Indonesia. Pertanyaan dan Jawaban

Terkait COVID-19. 2020; Available from:

https://www.kemkes.go.id/folder/view/full-content/structure-faq.html 68. Rashedi J, Poor BM, Asgharzadeh V, Pourostadi M, Kafil HS, Vegari A, et

al. Risk factors for covid-19. Infez Med. 2020;28(4):469–74.

69. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2. Am J Respir Crit Care Med. 2020;202(5):756–9.

70. Klein SL, Flanagan KL. Sex differences in immune responses. Nat Publ Gr.

71. Jin J, Bai P, He W, Wu F, Liu X, Han D, et al. Gender Differences in Patients With COVID-19 : Focus on Severity and Mortality. 2020;8(April):1–6.

72. Nurfaiza AR, Studi P, Dokter P, Kedokteran F, Lampung U. Obesity in patients with COVID-19. 2021;8(1).

73. Adimara A, Prahasanti K, Airlangga MP, Pendidikan P, Universitas D, Surabaya M. Obesitas Mempengaruhi Tingkat Keparahan Pasien COVID- 19. 2021;2071(September):222–42.

74. Centers for Disease Control and Prevention (CDC). People with Certain

Medical Conditions. 2022; Available from:

https://www.cdc.gov/coronavirus/2019-ncov/need-extra- precautions/people-with-medical-conditions.html